Zimmermann T

No ORCID on file · 3 papers in corpus
nonrandomized-trial 2020
Clinical pharmacology in drug development ·doi:10.1002/cpdd.851

Vilaprisan is a novel selective progesterone receptor modulator for the long-term treatment of uterine fibroids and endometriosis. This study investigated the pharmacokinetics, safety, and tolerability of vilaprisan in healthy Chinese postm…

nonrandomized-trial 2019
British journal of clinical pharmacology ·doi:10.1111/bcp.13992

AIMS: The study objective was to evaluate the pharmacokinetics of the selective progesterone receptor modulator vilaprisan in participants with hepatic impairment. Additionally, the safety and tolerability of vilaprisan were investigated. …

other 2004
Contraception ·doi:10.1016/j.contraception.2003.09.004

Long-cycle regimens with continuous use of oral contraceptives (OCs) for 3 or 6 months followed by a hormone-free interval of 7 days may reduce or prevent cycle-dependent and menses-related complaints. A representative survey carried out wi…